Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Zelman & Assoc Initiates Coverage On MasterBrand with Buy Rating

Zelman & Assoc Initiates Coverage On MasterBrand with Buy Rating

Zelman & Assoc initiates coverage on MasterBrand (NYSE:MBC) with a Buy rating.

byBenzinga Newsdesk

December 16, 2022

1 minute read

Zelman & Assoc initiates coverage on MasterBrand (NYSE:MBC) with a Buy rating.

Atara Lays Off 20% Of Its Workforce, Issues Update On Cell Therapies

By Vandana Singh

August 9, 3:01 PM

Atara Biotherapeutics Inc (NASDAQ:ATRA) will reduce cash burn by laying off 20% of its staff and extend the cash…

ATRA

Wells Fargo Maintains Overweight on Gartner, Raises Price Target to $345

By Benzinga Newsdesk

August 3, 8:39 AM

Wells Fargo analyst Seth Weber maintains Gartner (NYSE:IT) with a Overweight and raises the price target from $305 to $345.

Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

December 22, 8:58 AM

Shares of Rocket Lab USA, Inc. (NASDAQ: RKLB) shares rose sharply in pre-market trading after the company announced a new $515 million contract with a U.S. government customer.

ADN

DA Davidson Reiterates Buy on Helen Of Troy, Maintains $138 Price Target

By Benzinga Newsdesk

March 10, 5:34 AM

DA Davidson analyst Linda Bolton Weiser reiterates Helen Of Troy (NASDAQ:HELE) with a Buy and maintains $138 price target.

HELE

Zelman & Assoc Initiates Coverage On MasterBrand with Buy Rating

Related Posts

Atara Lays Off 20% Of Its Workforce, Issues Update On Cell Therapies

Wells Fargo Maintains Overweight on Gartner, Raises Price Target to $345

Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

DA Davidson Reiterates Buy on Helen Of Troy, Maintains $138 Price Target